Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Examples include, but are not limited to, patient demographics, hospital demographics, clinical characteristics, length of stay, resource utilization, and adjustments based on mix of services performed
Customers are instructed to inspect the included temperature indicator when the shipment arrives and contact the pharmacy before using the medication if the acceptable temperature range appears to have been exceeded
Pegzilarginase is a recombinant human arginase-1 enzyme replacement therapy designed to lower plasma arginine, the central biochemical driver of neurologic injury in ARG1-D
Patients who should wait before starting BPC-157: those with active malignancy or a personal history of hormone-sensitive cancer, pregnant patients, and anyone who has not yet completed a basic anti-inflammatory protocol for an acute injury
US$ 25.42
US$ 24.36
US$ 26.18
US$ 25.67
US$ 25.21
US$ 28.39
US$ 26.64
US$ 27.33
US$ 27.75
